An aberrant autocrine activation of the platelet-derived growth factor alpha-receptor in follicular and papillary thyroid carcinoma cell lines.
about
Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectivesInverse correlation between PDGFC expression and lymphocyte infiltration in human papillary thyroid carcinomas.Thyroid cancer: emerging role for targeted therapies.Genome-wide expression analysis suggests a crucial role of dysregulation of matrix metalloproteinases pathway in undifferentiated thyroid carcinomaGlioblastoma multiforme and papillary thyroid carcinoma - A rare combination of multiple primary malignancies.Macropinocytosis of the PDGF β-receptor promotes fibroblast transformation by H-RasG12V.Identification of Differentially Expressed Kinase and Screening Potential Anticancer Drugs in Papillary Thyroid Carcinoma.Additive effect by combination of Akt inhibitor, MK-2206, and PDGFR inhibitor, tyrphostin AG 1296, in suppressing anaplastic thyroid carcinoma cell viability and motility.PP121, a dual inhibitor of tyrosine and phosphoinositide kinases, inhibits anaplastic thyroid carcinoma cell proliferation and migration.Hepatic stellate cell-derived PDGFRα-enriched extracellular vesicles promote liver fibrosis in mice through SHP2.Significantly high expression of platelet-derived growth factor (PDGF) in benign nodules of the thyroid: relevance in the development of goitre recurrence?
P2860
Q26751274-E52E0561-4138-465E-B06B-146EE44488ACQ30962468-B69858ED-24A9-47E5-A55D-720D03546CC2Q35076227-9E290A32-4D27-4E5D-898E-1DE259636563Q35225620-2ED1FCA2-3A25-456D-BEEF-5552B88082B9Q35295159-94C9672C-201A-4118-B36D-42F36B233545Q36066649-DD72B65A-B10E-48BA-92E2-B1EB687A6D4FQ37293444-A13D7C58-B4C0-46AC-8492-52EC76F527FBQ38381918-2915ABAC-D88B-4E64-AD56-352EA1E69848Q38991018-5939F902-D5F6-4C52-AE44-2C45A043F393Q48185795-88FD86C8-3F6B-4AEA-8789-8A9B204E78B2Q54374121-FB88F0AF-E03F-4043-8A66-E601FB88B379
P2860
An aberrant autocrine activation of the platelet-derived growth factor alpha-receptor in follicular and papillary thyroid carcinoma cell lines.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
An aberrant autocrine activati ...... thyroid carcinoma cell lines.
@en
An aberrant autocrine activati ...... thyroid carcinoma cell lines.
@nl
type
label
An aberrant autocrine activati ...... thyroid carcinoma cell lines.
@en
An aberrant autocrine activati ...... thyroid carcinoma cell lines.
@nl
prefLabel
An aberrant autocrine activati ...... thyroid carcinoma cell lines.
@en
An aberrant autocrine activati ...... thyroid carcinoma cell lines.
@nl
P2093
P1433
P1476
An aberrant autocrine activati ...... y thyroid carcinoma cell lines
@en
P2093
Hsiao-Fen Weng
Jen-Der Lin
Kuei-Tien Chen
Miaw-Jene Liou
P304
P356
10.1016/J.CANLET.2005.01.039
P407
P577
2005-08-29T00:00:00Z